Concepts (98)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antibodies, Protozoan | 5 | 2022 | 82 | 1.350 |
Why?
|
| Plasmodium falciparum | 3 | 2022 | 146 | 1.020 |
Why?
|
| Nerve Compression Syndromes | 1 | 2025 | 2 | 0.960 |
Why?
|
| Muscular Atrophy | 1 | 2025 | 13 | 0.960 |
Why?
|
| Malaria, Falciparum | 4 | 2022 | 91 | 0.930 |
Why?
|
| Osteoarthritis | 2 | 2021 | 25 | 0.860 |
Why?
|
| Adipose Tissue | 1 | 2025 | 180 | 0.850 |
Why?
|
| Antigens, Protozoan | 4 | 2022 | 74 | 0.830 |
Why?
|
| Muscle, Skeletal | 1 | 2025 | 308 | 0.790 |
Why?
|
| Nutrition Surveys | 2 | 2021 | 263 | 0.780 |
Why?
|
| Pregnancy Complications, Parasitic | 2 | 2018 | 10 | 0.700 |
Why?
|
| Vitamin B 12 | 1 | 2021 | 23 | 0.700 |
Why?
|
| Drinking | 1 | 2021 | 35 | 0.690 |
Why?
|
| Coffee | 1 | 2021 | 20 | 0.690 |
Why?
|
| Folic Acid | 1 | 2021 | 49 | 0.690 |
Why?
|
| Nutrition Policy | 1 | 2021 | 64 | 0.670 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2021 | 53 | 0.670 |
Why?
|
| Eating | 1 | 2021 | 164 | 0.620 |
Why?
|
| Absenteeism | 1 | 2019 | 14 | 0.610 |
Why?
|
| Diabetes Mellitus | 2 | 2021 | 532 | 0.580 |
Why?
|
| Placenta | 2 | 2018 | 113 | 0.540 |
Why?
|
| Health Status | 1 | 2019 | 432 | 0.470 |
Why?
|
| Students | 1 | 2019 | 617 | 0.400 |
Why?
|
| Cross-Sectional Studies | 5 | 2025 | 3077 | 0.380 |
Why?
|
| Adult | 7 | 2025 | 13458 | 0.270 |
Why?
|
| Young Adult | 5 | 2021 | 4936 | 0.260 |
Why?
|
| Humans | 14 | 2025 | 42163 | 0.240 |
Why?
|
| Retrospective Studies | 5 | 2025 | 2485 | 0.240 |
Why?
|
| Heel | 1 | 2025 | 1 | 0.240 |
Why?
|
| Foot | 1 | 2025 | 10 | 0.240 |
Why?
|
| Female | 8 | 2025 | 24018 | 0.240 |
Why?
|
| Male | 7 | 2025 | 22779 | 0.210 |
Why?
|
| Adolescent | 3 | 2021 | 5950 | 0.210 |
Why?
|
| Cameroon | 3 | 2018 | 35 | 0.200 |
Why?
|
| Middle Aged | 3 | 2025 | 11819 | 0.200 |
Why?
|
| Prevalence | 2 | 2025 | 1597 | 0.200 |
Why?
|
| Aged | 3 | 2025 | 7982 | 0.190 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2025 | 577 | 0.180 |
Why?
|
| Malaria | 1 | 2022 | 90 | 0.180 |
Why?
|
| Parkinson Disease | 1 | 2024 | 207 | 0.180 |
Why?
|
| Sodium, Dietary | 1 | 2021 | 22 | 0.170 |
Why?
|
| Seafood | 1 | 2021 | 24 | 0.170 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2021 | 36 | 0.170 |
Why?
|
| Hospitalization | 1 | 2024 | 482 | 0.160 |
Why?
|
| Atrial Fibrillation | 1 | 2021 | 121 | 0.160 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2019 | 22 | 0.150 |
Why?
|
| Myocardial Infarction | 1 | 2021 | 242 | 0.150 |
Why?
|
| Overweight | 1 | 2021 | 248 | 0.150 |
Why?
|
| Healthcare Disparities | 1 | 2024 | 573 | 0.140 |
Why?
|
| Phenotype | 1 | 2021 | 774 | 0.140 |
Why?
|
| Pregnancy Outcome | 1 | 2018 | 92 | 0.140 |
Why?
|
| Family | 1 | 2019 | 192 | 0.140 |
Why?
|
| Pregnancy | 3 | 2018 | 1737 | 0.140 |
Why?
|
| Age Factors | 1 | 2021 | 1139 | 0.140 |
Why?
|
| Heart Failure | 1 | 2021 | 298 | 0.130 |
Why?
|
| Stroke | 1 | 2021 | 348 | 0.130 |
Why?
|
| Schools | 1 | 2019 | 283 | 0.130 |
Why?
|
| Body Mass Index | 1 | 2021 | 916 | 0.130 |
Why?
|
| Models, Statistical | 1 | 2017 | 190 | 0.130 |
Why?
|
| Antibody Affinity | 1 | 2015 | 21 | 0.120 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2015 | 2 | 0.120 |
Why?
|
| Asthma | 1 | 2019 | 410 | 0.110 |
Why?
|
| Urinary Tract Infections | 1 | 2015 | 42 | 0.110 |
Why?
|
| Socioeconomic Factors | 1 | 2019 | 1221 | 0.110 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2015 | 112 | 0.110 |
Why?
|
| Risk Factors | 2 | 2021 | 3942 | 0.110 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 2803 | 0.110 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 1058 | 0.100 |
Why?
|
| Child | 2 | 2019 | 3381 | 0.100 |
Why?
|
| United States | 2 | 2021 | 5072 | 0.100 |
Why?
|
| Obesity | 1 | 2021 | 1131 | 0.100 |
Why?
|
| Kidney | 1 | 2015 | 363 | 0.100 |
Why?
|
| Merozoite Surface Protein 1 | 2 | 2022 | 34 | 0.080 |
Why?
|
| Immunoglobulin G | 2 | 2022 | 253 | 0.080 |
Why?
|
| Immunization, Secondary | 1 | 2023 | 15 | 0.050 |
Why?
|
| Half-Life | 1 | 2023 | 63 | 0.050 |
Why?
|
| Antibody Formation | 1 | 2022 | 75 | 0.050 |
Why?
|
| Antibodies, Neutralizing | 1 | 2023 | 118 | 0.050 |
Why?
|
| Immunoglobulin M | 1 | 2022 | 87 | 0.050 |
Why?
|
| Social Isolation | 1 | 2022 | 34 | 0.050 |
Why?
|
| Antibodies, Viral | 1 | 2023 | 295 | 0.040 |
Why?
|
| Vaccination | 1 | 2023 | 332 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2024 | 1574 | 0.040 |
Why?
|
| Infant | 1 | 2022 | 1143 | 0.040 |
Why?
|
| Merozoites | 1 | 2018 | 3 | 0.040 |
Why?
|
| Parasitemia | 1 | 2018 | 13 | 0.040 |
Why?
|
| Infant, Low Birth Weight | 1 | 2018 | 36 | 0.040 |
Why?
|
| Medicare | 1 | 2021 | 326 | 0.040 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2018 | 72 | 0.030 |
Why?
|
| Health Status Disparities | 1 | 2024 | 705 | 0.030 |
Why?
|
| Protozoan Proteins | 1 | 2018 | 196 | 0.030 |
Why?
|
| Placenta Diseases | 1 | 2015 | 5 | 0.030 |
Why?
|
| Hypertrophy | 1 | 2015 | 34 | 0.030 |
Why?
|
| Nephrectomy | 1 | 2015 | 29 | 0.030 |
Why?
|
| Hawaii | 1 | 2021 | 2004 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2015 | 132 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2015 | 1266 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2015 | 1516 | 0.020 |
Why?
|